SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6790)4/10/1998 12:16:00 PM
From: Pat Jacks  Read Replies (2) | Respond to of 23519
 
I don't remember Leland referring to the new items in the package insert. On the subject of overdose of Viagra, he simply stated that because Viagra's response time was so much longer than Muse, a person might be inclined to take more and possibly overdose. Who knows what "Viagra overdose" amounts to.



To: BigKNY3 who wrote (6790)4/10/1998 1:35:00 PM
From: Jman  Read Replies (2) | Respond to of 23519
 
BigKNY3,
I am not a bio expert, but can you explain to me why the FDA
would approve a label and the print/TV ads, and then later, after
they are in production, ask for revisions/changes (I believe this is
happening to Vivus). Isn't that the idea of FDA approval - that
what they approve is ok to do?

Thanks,
Jman


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News